Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie van Tol

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Atherosclerosis|October 19, 2004
Analysis of gender-specific atherosclerosis susceptibility in transgenic[hCETP]25DS rat modelVictoria L M Herrera, Aristides Tsikoudakis, Tamara Didishvili, et al.
Diabetes|November 25, 2005
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglyceridesRindert de Vries, Frank G Perton, Geesje M Dallinga-Thie, et al.
Alcoholism, Clinical and Experimental Research|April 22, 2004
Effect of moderate alcohol consumption on parameters of reverse cholesterol transport in postmenopausal womenAafje Sierksma, Susanne H F Vermunt, Inge M Lankhuizen, et al.
Biochimica Et Biophysica Acta|June 16, 2009
Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolismRien van Haperen, Hannelore Samyn, Teus van Gent, et al.
Circulation|May 8, 2002
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response studyGreetje J de Grooth, Jan Albert Kuivenhoven, Anton F H Stalenhoef, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based studySusanna E Borggreve, Hans L Hillege, Bruce H R Wolffenbuttel, et al.
European Heart Journal|April 6, 2007
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglyceridesSusanna E Borggreve, Hans L Hillege, Geesje M Dallinga-Thie, et al.
Atherosclerosis|June 17, 2006
Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphismPeter Henneman, Frank G Schaap, Louis M Havekes, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2005
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglyceridesSusanna E Borggreve, Hans L Hillege, Bruce H R Wolffenbuttel, et al.
Journal of Lipid Research|May 20, 2003
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapyIris J A M Jonkers, Augustinus H M Smelt, Hiroaki Hattori, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Atherosclerosis|October 19, 2004
Analysis of gender-specific atherosclerosis susceptibility in transgenic[hCETP]25DS rat modelVictoria L M Herrera, Aristides Tsikoudakis, Tamara Didishvili, et al.
Diabetes|November 25, 2005
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglyceridesRindert de Vries, Frank G Perton, Geesje M Dallinga-Thie, et al.
Alcoholism, Clinical and Experimental Research|April 22, 2004
Effect of moderate alcohol consumption on parameters of reverse cholesterol transport in postmenopausal womenAafje Sierksma, Susanne H F Vermunt, Inge M Lankhuizen, et al.
Biochimica Et Biophysica Acta|June 16, 2009
Novel roles of hepatic lipase and phospholipid transfer protein in VLDL as well as HDL metabolismRien van Haperen, Hannelore Samyn, Teus van Gent, et al.
Circulation|May 8, 2002
Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response studyGreetje J de Grooth, Jan Albert Kuivenhoven, Anton F H Stalenhoef, et al.
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based studySusanna E Borggreve, Hans L Hillege, Bruce H R Wolffenbuttel, et al.
European Heart Journal|April 6, 2007
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglyceridesSusanna E Borggreve, Hans L Hillege, Geesje M Dallinga-Thie, et al.
Atherosclerosis|June 17, 2006
Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphismPeter Henneman, Frank G Schaap, Louis M Havekes, et al.
The Journal of Clinical Endocrinology and Metabolism|April 21, 2005
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglyceridesSusanna E Borggreve, Hans L Hillege, Bruce H R Wolffenbuttel, et al.
Journal of Lipid Research|May 20, 2003
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapyIris J A M Jonkers, Augustinus H M Smelt, Hiroaki Hattori, et al.
Pageof 6